Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury

Toxicology

Volumn 324, Issue 1, 2014, Pages 147-157

  Pavkovic, Mira ^a   Riefke, Björn ^a   Ellinger Ziegelbauer, Heidrun ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Biomarker; Cisplatin; Nephrotoxicity; Urinary microRNAs

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; MICRORNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOCHEMICAL ANALYSIS; CELL CYCLE REGULATION; CONTROLLED STUDY; DNA DAMAGE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RNA ISOLATION; URINALYSIS; URINE LEVEL; ACUTE KIDNEY FAILURE; ANIMAL; CHEMICALLY INDUCED DISORDER; CLUSTER ANALYSIS; DISEASE MODEL; DNA MICROARRAY; GENETIC MARKER; GENETICS; METHODOLOGY; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; TIME; URINARY MICRORNAS; URINE; WISTAR RAT;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

BIOMARKER; CISPLATIN; NEPHROTOXICITY; URINARY MICRORNAS;

ACUTE KIDNEY INJURY; ANIMALS; CISPLATIN; CLUSTER ANALYSIS; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENETIC MARKERS; MALE; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, WISTAR; TIME FACTORS; URINALYSIS;

EID: 84908248939     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2014.05.005     Document Type: Article

References (43)

1. Argyropoulos C., Wang K., McClarty S., Huang D., Bernardo J., Ellis D., Orchard T., Galas D., Johnson J. Urinary microRNA profiling in the nephropathy of type 1 diabetes. PLoS ONE 2013, 8:e54662.
2. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchell P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:5003-5008.
3. Bala S., Petrasek J., Mundkur S., Catalano D., Levin I., Ward J., Alao H., Kodys K., Szabo G. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56:1946-1957.
4. Bartel D.P. MicroRNAs: genomics biogenesis, mechanism, and function. Cell 2004, 116:281-297.
5. Bhatt K., Mi Q.S., Dong Z. microRNAs in kidneys: biogenesis, regulation, and pathophysiological roles. Am. J. Physiol. Renal Physiol. 2011, 300:F602-F610.
6. Ceman S., Saugstad J. MicroRNAs: meta-controllers of gene expression in synaptic activity emerge as genetic and diagnostic markers of human disease. Pharmacol. Ther. 2011, 130:26-37.
7. Cheng Y., Wang X., Yang J., Duan X., Yao Y., Shi X., Chen Z., Fan Z., Liu X., Qin S., Tang X., Zhang C. A translational study of urine miRNAs in acute myocardial infarction. J. Mol. Cell. Cardiol. 2012, 53:668-676.
8. Cortez M.A., Bueso-Ramos C., Ferdin J., Lopez-Berestein G., Sood A.K., Calin G.A. MicroRNAs in body fluids - the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 2011, 8:467-477.
9. Etheridge A., Lee I., Hood L., Galas D., Wang K. Extracellular microRNA: a new source of biomarkers. Mutat. Res. 2011, 717:85-90.
10. Filipowicz W., Grosshans H. The liver-specific microRNA miR-122: biology and therapeutic potential. Prog. Drug Res. 2011, 67:221-238.
11. Hanke M., Hoefig K., Merz H., Feller A.C., Kausch I., Jocham D., Warnecke J.M., Sczakiel G. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol. Oncol. 2010, 28:655-661.
12. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 2012, 12:613-626.
13. Hoy A.M., Buck A.H. Extracellular small RNAs: what, where, why?. Biochem. Soc. Trans. 2012, 40:886-890.
14. Ji X., Takahashi R., Hiura Y., Hirokawa G., Fukushima Y., Iwai N. Plasma miR-208 as a biomarker of myocardial injury. Clin. Chem. 2009, 55:1944-1949.
15. Kanki M., Moriguchi A., Sasaki D., Mitori H., Yamada A., Unami A., Miyamae Y. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. Toxicology 2014, 324:158-168.
16. Krol J., Loedige I., Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 2010, 11:597-610.
17. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
18. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
19. Li J.Y., Yong T.Y., Michael M.Z., Gleadle J.M. Review: the role of microRNAs in kidney disease. Nephrology (Carlton) 2010, 15:599-608.
20. Li T., Cao H., Zhuang J., Wan J., Guan M., Yu B., Li X., Zhang W. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin. Chim. Acta 2011, 412:66-70.
21. McDonald J.S., Milosevic D., Reddi H.V., Grebe S.K., Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin. Chem. 2011, 57:833-840.
22. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518.
23. Ozer J.S., Dieterle F., Troth S., Perentes E., Cordier A., Verdes P., Staedtler F., Mahl A., Grenet O., Roth D.R., Wahl D., Legay F., Holder D., Erdos Z., Vlasakova K., Jin H., Yu Y., Muniappa N., Forest T., Clouse H.K., Reynolds S., Bailey W.J., Thudium D.T., Topper M.J., Skopek T.R., Sina J.F., Glaab W.E., Vonderscher J., Maurer G., Chibout S.D., Sistare F.D., Gerhold D.L. A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat. Biotechnol. 2010, 28:486-494.
24. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Muller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
25. Pavkovic M., Riefke B., Gutberlet K., Raschke M., Ellinger-Ziegelbauer H. Comparison of the Mesoscale Discovery and Luminex multiplex platforms for measurement of urinary biomarkers in a cisplatin rat kidney injury model. J. Pharmacol. Toxicol. Methods 2014, 69:196-204.
26. Ramachandran K., Saikumar J., Bijol V., Koyner J.L., Qian J., Betensky R.A., Waikar S.S., Vaidya V.S. Human miRNome profiling identifies MicroRNAs differentially present in the urine after kidney injury. Clin. Chem. 2013, 59:1742-1752.
27. Reid G., Kirschner M.B., van Zandwijk N. Circulating microRNAs: association with disease and potential use as biomarkers. Crit. Rev. Oncol. Hematol. 2011, 80:193-208.
28. Saal S., Harvey S.J. MicroRNAs and the kidney: coming of age. Curr. Opin. Nephrol. Hypertens. 2009, 18:317-323.
29. Saikumar J., Hoffmann D., Kim T.M., Gonzalez V.R., Zhang Q., Goering P.L., Brown R.P., Bijol V., Park P.J., Waikar S.S., Vaidya V.S. Expression, circulation, and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol. Sci. 2012, 129:256-267.
30. Tian Z., Greene A.S., Pietrusz J.L., Matus I.R., Liang M. MicroRNA-target pairs in the rat kidney identified by microRNA microarray, proteomic, and bioinformatic analysis. Genome Res. 2008, 18:404-411.
31. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011, 39:7223-7233.
32. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
33. Wang G., Kwan B.C., Lai F.M., Chow K.M., Li P.K., Szeto C.C. Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis. Am. J. Nephrol. 2012, 36:412-418.
34. Wang G., Tam L.S., Li E.K., Kwan B.C., Chow K.M., Luk C.C., Li P.K., Szeto C.C. Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J. Rheumatol. 2010, 37:2516-2522.
35. Wang K., Zhang S., Marzolf B., Troisch P., Brightman A., Hu Z., Hood L.E., Galas D.J. Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:4402-4407.
36. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010, 38:7248-7259.
37. Wang N., Zhou Y., Jiang L., Li D., Yang J., Zhang C.Y., Zen K. Urinary MicroRNA-10a and MicroRNA-30d serve as novel sensitive and specific biomarkers for kidney injury. PLoS ONE 2012, 7:e51140.
38. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
39. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75:855-862.
40. Yamaura Y., Nakajima M., Takagi S., Fukami T., Tsuneyama K., Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS ONE 2012, 7:e30250.
41. Yang X., Greenhaw J., Shi Q., Su Z., Qian F., Davis K., Mendrick D.L., Salminen W.F. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol. Sci. 2012, 125:335-344.
42. Yao X., Panichpisal K., Kurtzman N., Nugent K. Cisplatin nephrotoxicity: a review. Am. J. Med. Sci. 2007, 334:115-124.
43. Zhou Y., Vaidya V.S., Brown R.P., Zhang J., Rosenzweig B.A., Thompson K.L., Miller T.J., Bonventre J.V., Goering P.L. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol. Sci. 2008, 101:159-170.